// App-Quantinova.ai

e16035 : The association of renal function with safety and efficacy of cisplatin plus S-1 (CS) therapy and docetaxel plus cisplatin plus S-1 (DCS) therapy in patients with advanced gastric cancer (AGC): An additional analysis of JCOG1013.

Researchers

Presenter

  • Shuichi Hironaka

Principal Investigators

  • Ryo Sadachi

  • Nozomu Machida

  • Satoru Iwasa

  • Yasuhide Yamada

  • Mitsuru Sasako

  • Takaki Yoshikawa

  • Narikazu Boku

  • Masanori Terashima

Medical Centers

  • Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan

  • Japan Clinical Oncology Group Data Center, National Cancer Center, Tokyo, Japan

  • Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan

  • Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

  • Comprehensive Cancer Center, National Center for Global Health and Medicine, Tokyo, Japan

  • Yodogawa Christian Hospital, Higashiyodogawa-Ku, Japan

  • Kanagawa Cancer Center, Yokohama, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Shizuoka Cancer Center Hospital, Shizuoka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • Creatinine

Drug/Treatment

  • Docetaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • JCOG1013

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved